Current Ratio in % of Lyra Therapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lyra Therapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2020 to Q3 2025.
  • Lyra Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 293%, a 33% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Lyra Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 293% -146% -33% 30 Sep 2025
Q2 2025 323% -156% -33% 30 Jun 2025
Q1 2025 344% -238% -41% 31 Mar 2025
Q4 2024 391% -224% -36% 31 Dec 2024
Q3 2024 439% -221% -34% 30 Sep 2024
Q2 2024 480% -259% -35% 30 Jun 2024
Q1 2024 582% -213% -27% 31 Mar 2024
Q4 2023 615% -4.8% -0.77% 31 Dec 2023
Q3 2023 660% +158% +32% 30 Sep 2023
Q2 2023 739% +342% +86% 30 Jun 2023
Q1 2023 795% +452% +132% 31 Mar 2023
Q4 2022 620% +86% +16% 31 Dec 2022
Q3 2022 502% -336% -40% 30 Sep 2022
Q2 2022 396% -1114% -74% 30 Jun 2022
Q1 2022 343% -1442% -81% 31 Mar 2022
Q4 2021 534% -987% -65% 31 Dec 2021
Q3 2021 838% -311% -27% 30 Sep 2021
Q2 2021 1510% 30 Jun 2021
Q1 2021 1786% 31 Mar 2021
Q4 2020 1521% 31 Dec 2020
Q3 2020 1149% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.